Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a ...
Ozanimodâ–¼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. The Mayo Clinic says MS causes the breakdown of the protective covering of nerve fibers, known as ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other ...
Columnist Ben Hofmeister reflects on his journey treating depression and what he wishes he knew earlier about MS and mental health.
FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.